Gilead ties up with generic drugmakers for COVID-19 drug supply
Islamabad (Reuters) – Gilead Sciences Inc said on Tuesday it has signed non-exclusive licensing pacts with five generic drugmakers based
Read MoreIslamabad (Reuters) – Gilead Sciences Inc said on Tuesday it has signed non-exclusive licensing pacts with five generic drugmakers based
Read MoreTokyo (Reuters) – More than 90 percent of hospital beds secured for COVID-19 patients in Tokyo have already been occupied,
Read MoreHongkong (Reuters) – China has issued a lengthy rebuttal of what it said were 24 “preposterous allegations” by some leading
Read MoreKabul (Reuters) – More than a third of confirmed coronavirus cases in the Afghan capital have been among doctors and
Read MoreKabul (Reuters) – Iranian border guards killed 45 Afghan migrant workers trying to cross into Iran this month by forcing
Read MoreMumbai (Reuters) – Hundreds of Indian police have tested positive for the coronavirus in recent days, raising alarm among an
Read MoreAndhra (Reuters) – At least 11 people were killed in India in a gas leak at a South Korean-owned factory
Read MoreWashington (Reuters) – The U.S. special envoy on Afghanistan is on a mission to press Taliban negotiators in Doha and
Read MoreSydney (Reuters) – Coronavirus cases in Asia rose to a quarter of a million on Tuesday, according to a Reuters
Read MoreWashington (Reuters) – U.S. Defense Secretary Mark Esper said on Tuesday that the Taliban were not living up to their
Read More